Acquired by UnitedHealth in Oct 2022
CHNG - Change Healthcare Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Nashville,
United States
Type: Equity
CHNG price evolution
CHNG
| (in millions $) | 1 May 2023 | 30 Jun 2022 | 1 May 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $94.01 | $252.3 | $96.01 | |
| Short term investments | ||||
| Net receivables | $717.68 | $882.95 | $781.53 | |
| Inventory | ||||
| Total current assets | $1146.4 | $1312.91 | $1153.26 | |
| Long term investments | ||||
| Property, plant & equipment | $188.2 | $207.02 | $216.55 | |
| Goodwill & intangible assets | $7688.68 | $7812.51 | $7936.06 | |
| Total noncurrent assets | $8490.58 | $8619.59 | $8694.72 | |
| Total investments | ||||
| Total assets | $9636.98 | $9932.5 | $9847.98 | |
| Current liabilities | ||||
| Accounts payable | $114.77 | $104.27 | $98.87 | |
| Deferred revenue | $409.95 | $469.1 | $431.24 | |
| Short long term debt | $24.72 | $31.73 | $39.52 | |
| Total current liabilities | $932.8 | $1079.67 | $1043.1 | |
| Long term debt | $4535.15 | $4580.09 | $4629.82 | |
| Total noncurrent liabilities | $5413.29 | $5576.72 | $5557.28 | |
| Total debt | $4559.86 | $4664.1 | $4669.34 | |
| Total liabilities | $6346.1 | $6656.39 | $6600.39 | |
| Shareholders' equity | ||||
| Retained earnings | -$1123.25 | -$1100.08 | -$1107.17 | |
| Other shareholder equity | $29.18 | $35.12 | $21.08 | |
| Total shareholder equity | $3290.89 | $3276.11 | $3247.59 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $252.3 | $113.1 | $410.4 | $48.89 |
| Short term investments | ||||
| Net receivables | $720.12 | $732.61 | $740.11 | $759.5 |
| Inventory | ||||
| Total current assets | $1312.91 | $1118.83 | $1401.18 | $980.46 |
| Long term investments | $146.5 | |||
| Property, plant & equipment | $207.02 | $267.78 | $206.2 | $197.26 |
| Goodwill & intangible assets | $7812.51 | $8295.86 | $8161.13 | $4604.43 |
| Total noncurrent assets | $8619.59 | $8993.79 | $8706.2 | $5223.68 |
| Total investments | $146.5 | |||
| Total assets | $9932.5 | $10112.62 | $10107.38 | $6204.14 |
| Current liabilities | ||||
| Accounts payable | $117.33 | $68.22 | $88.4 | $133.18 |
| Deferred revenue | $469.1 | $436.67 | $302.31 | $437.64 |
| Short long term debt | $31.73 | $57.95 | $278.78 | $2.79 |
| Total current liabilities | $1079.67 | $1047.12 | $1059.79 | $889.78 |
| Long term debt | $4632.37 | $4810.17 | $4710.29 | $5787.15 |
| Total noncurrent liabilities | $5576.72 | $5813.27 | $5762.14 | $6219.14 |
| Total debt | $4664.1 | $4868.12 | $4989.07 | $5789.94 |
| Total liabilities | $6656.39 | $6860.39 | $6821.93 | $7108.92 |
| Shareholders' equity | ||||
| Retained earnings | -$1100.08 | -$1042.69 | -$930.06 | -$930.06 |
| Other shareholder equity | $35.12 | $11.22 | -$7.37 | -$7.37 |
| Total shareholder equity | $3276.11 | $3252.23 | $3285.45 | -$904.79 |
| (in millions $) | 1 May 2023 | 30 Jun 2022 | 1 May 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $884.47 | $920.13 | $866.07 | |
| Cost of revenue | $357.1 | $354.11 | ||
| Gross Profit | $527.37 | $557.67 | $511.96 | |
| Operating activities | ||||
| Research & development | $74.2 | $67.31 | ||
| Selling, general & administrative | $197.89 | $187.28 | ||
| Total operating expenses | $500.12 | $504.84 | $483.25 | |
| Operating income | $27.25 | $28.71 | ||
| Income from continuing operations | ||||
| EBIT | $24.39 | $23.85 | ||
| Income tax expense | -$9.31 | -$13.3 | -$10.12 | |
| Interest expense | $56.87 | -$56.96 | $58.43 | |
| Net income | ||||
| Net income | -$23.17 | $7.09 | -$24.47 | |
| Income (for common shares) | -$23.17 | -$24.47 | ||
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3480.82 | $3090.42 | $196.79 | $3281.73 |
| Cost of revenue | $1415.27 | $1335.08 | $71.44 | $1354.65 |
| Gross Profit | $2065.55 | $1755.35 | $125.36 | $1927.07 |
| Operating activities | ||||
| Research & development | $277.93 | $227.04 | $11.56 | $202.24 |
| Selling, general & administrative | $734.55 | $686.64 | $39.89 | $821.08 |
| Total operating expenses | $1928.74 | $1655.28 | $836.54 | $1448.53 |
| Operating income | $136.81 | $100.07 | -$711.18 | $478.54 |
| Income from continuing operations | ||||
| EBIT | $128.24 | $97.84 | -$1074.2 | $497.62 |
| Income tax expense | -$48.61 | -$35.19 | -$143.25 | -$4.48 |
| Interest expense | $234.24 | $245.24 | $16.65 | $325.43 |
| Net income | ||||
| Net income | -$57.39 | -$112.21 | -$947.6 | $176.67 |
| Income (for common shares) | -$57.39 | -$112.21 | -$947.6 | $176.67 |
| (in millions $) | 30 Jun 2022 | 1 May 2022 | 31 Dec 2021 | 30 Oct 2021 |
|---|---|---|---|---|
| Net income | -$23.17 | -$24.47 | -$40.01 | |
| Operating activities | ||||
| Depreciation | $178.71 | $178.2 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $49.96 | $24.81 | ||
| Total cash flows from operations | $83.31 | $177.44 | $261.35 | |
| Investing activities | ||||
| Capital expenditures | -$79.53 | -$65.8 | ||
| Investments | ||||
| Total cash flows from investing | -$79.53 | -$276.94 | -$65.46 | -$127.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.27 | $0.83 | ||
| Net borrowings | -$104.25 | -$84.14 | ||
| Total cash flows from financing | -$160.65 | -$280.91 | -$96.6 | -$166.32 |
| Effect of exchange rate | -$1.42 | $0.17 | $0.22 | $0.12 |
| Change in cash and equivalents | -$158.29 | $139.2 | $15.6 | -$32.69 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$57.39 | -$112.21 | -$947.6 | $176.67 |
| Operating activities | ||||
| Depreciation | $711.97 | $621.49 | $30.84 | $292.69 |
| Business acquisitions & disposals | -$323.75 | -$558.99 | $144.37 | |
| Stock-based compensation | $95.73 | $59.02 | $1.7 | $20.14 |
| Total cash flows from operations | $696.88 | $586.2 | -$153.93 | $287.68 |
| Investing activities | ||||
| Capital expenditures | -$276.28 | -$246.38 | -$13 | -$246.99 |
| Investments | $7.33 | |||
| Total cash flows from investing | -$276.94 | -$568.03 | -$564.66 | -$105.68 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.93 | $608.68 | -$7.22 | |
| Net borrowings | -$196.38 | -$240 | $519.2 | -$153 |
| Total cash flows from financing | -$280.44 | -$294.34 | $1125.57 | -$182.09 |
| Effect of exchange rate | $0.02 | -$1.02 | ||
| Change in cash and equivalents | -$297.3 | -$1.12 | ||
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.03 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |